These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of an Imidazole-Containing Schiff Base of an Aromatic Sulfonamide on the Cytotoxic Efficacy of N,N-Coordinated Half-Sandwich Ruthenium(II) Maji M; Acharya S; Bhattacharya I; Gupta A; Mukherjee A Inorg Chem; 2021 Apr; 60(7):4744-4754. PubMed ID: 33760599 [TBL] [Abstract][Full Text] [Related]
4. DNA targeting half sandwich Ru(II)- Mondal A; Sen U; Roy N; Muthukumar V; Sahoo SK; Bose B; Paira P Dalton Trans; 2021 Jan; 50(3):979-997. PubMed ID: 33355328 [TBL] [Abstract][Full Text] [Related]
6. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates. Riedl CA; Flocke LS; Hejl M; Roller A; Klose MH; Jakupec MA; Kandioller W; Keppler BK Inorg Chem; 2017 Jan; 56(1):528-541. PubMed ID: 27996251 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of (ɳ Ahmad Khan R; Al-Lohedan HA; Abul Farah M; Sajid Ali M; Alsalme A; Mashay Al-Anazi K; Tabassum S J Biomol Struct Dyn; 2019 Sep; 37(15):3905-3913. PubMed ID: 30257617 [TBL] [Abstract][Full Text] [Related]
8. New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent. Guerriero A; Oberhauser W; Riedel T; Peruzzini M; Dyson PJ; Gonsalvi L Inorg Chem; 2017 May; 56(10):5514-5518. PubMed ID: 28443659 [TBL] [Abstract][Full Text] [Related]
9. GSH-resistant and highly cytoselective ruthenium(II)- Kar B; Das U; De S; Pete S; Sharma S A; Roy N; S K AK; Panda D; Paira P Dalton Trans; 2021 Aug; 50(30):10369-10373. PubMed ID: 34308466 [TBL] [Abstract][Full Text] [Related]
10. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, Characterization, and Cytotoxicity of Morpholine-Containing Ruthenium(II) Chatterjee R; Bhattacharya I; Roy S; Purkait K; Koley TS; Gupta A; Mukherjee A Inorg Chem; 2021 Aug; 60(16):12172-12185. PubMed ID: 34346215 [TBL] [Abstract][Full Text] [Related]
12. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity. Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of 3D colon cancer stem cell spheroids by cytotoxic Ru Acharya S; Ghosh S; Maji M; Parambil ARU; Singh S; Mukherjee A Chem Commun (Camb); 2020 May; 56(40):5421-5424. PubMed ID: 32292957 [TBL] [Abstract][Full Text] [Related]
17. Coordination Chemistry of Organoruthenium Compounds with Benzoylthiourea Ligands and their Biological Properties. Parveen S; Tong KKH; Khawar Rauf M; Kubanik M; Shaheen MA; Söhnel T; Jamieson SMF; Hanif M; Hartinger CG Chem Asian J; 2019 Apr; 14(8):1262-1270. PubMed ID: 30706633 [TBL] [Abstract][Full Text] [Related]
18. New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity. Ganeshpandian M; Loganathan R; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M Dalton Trans; 2014 Jan; 43(3):1203-19. PubMed ID: 24177707 [TBL] [Abstract][Full Text] [Related]
19. N- and S-donor leaving groups in triazole-based ruthena(ii)cycles: potent anticancer activity, selective activation, and mode of action studies. Riedl CA; Hejl M; Klose MHM; Roller A; Jakupec MA; Kandioller W; Keppler BK Dalton Trans; 2018 Mar; 47(13):4625-4638. PubMed ID: 29520401 [TBL] [Abstract][Full Text] [Related]